Voxel

Voxel FCF/Debt

The Free Cash Flow to Debt Ratio of Voxel (VOX.WA) as of Oct 21, 2026 is 22.01 %. In the previous year, Free Cash Flow to Debt Ratio was 40.76 % — a change of -45.99% (lower).

FCF/Debt

22.01 %

YoY

-45.99%

Last updated:

Free Cash Flow to Debt Ratio of Voxel is 2025 22.01 % . Free Cash Flow to Debt Ratio of Voxel was 2024 40.76 % . It decreases by -45.99% lower compared to the previous year.

The Voxel FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2018
31.43 PLN
Jan 1, 2019
19.92 PLN
Jan 1, 2020
20.11 PLN
Jan 1, 2021
44.75 PLN
Jan 1, 2022
47.07 PLN
Jan 1, 2023
58.38 PLN
Jan 1, 2024
40.76 PLN
Jan 1, 2025
22.01 PLN
The Voxel FCF/Debt history
YEARFCF/DebtYoY
22.01 %-45.99%
40.76 %-30.18%
58.38 %+24.02%
47.07 %+5.20%
44.75 %+122.51%
20.11 %+0.98%
19.92 %-36.63%
31.43 %-52.63%
66.35 %+71.17%
38.76 %-41.70%
66.48 %+709.67%
8.21 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Voxel Stock analysis

What does Voxel do? Voxel SA generates revenue through medical services including diagnostic imaging, teleradiology, and outsourcing, alongside IT systems for hospitals and diagnostic centers. The company serves healthcare institutions with its diagnostic imaging solutions, teleradiology services, and IT infrastructure, targeting hospitals and diagnostic centers as key clients. It operates two subsidiaries, Alteris SA (95.24%-owned) and CDO Sp. z o.o. (wholly owned), which support its service offerings. Voxel SA previously held a stake in Centrum Diagnostyki i Terapii Onkologicznej Sp. z o.o. but sold it on November 7, 2012. The company's primary revenue streams come from providing diagnostic imaging services, teleradiology, and IT systems to healthcare facilities. Its subsidiaries, Alteris SA and CDO Sp. z o.o., contribute to the delivery of these services, enhancing its market presence in medical technology. Voxel SA focuses on institutional clients such as hospitals and diagnostic centers, leveraging its IT systems to improve operational efficiency in healthcare settings. Voxel SA's business model centers on delivering specialized medical services and technology solutions to healthcare providers. It operates through its subsidiaries, Alteris SA and CDO Sp. z o.o., to expand its service capabilities. The company's revenue is derived from contracts with hospitals and diagnostic centers for diagnostic imaging, teleradiology, and IT system implementation, with no mention of additional revenue sources beyond these core services. Voxel is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Voxel stock

Free Cash Flow to Debt Ratio of Voxel is 22.01 % in 2025.

Free Cash Flow to Debt Ratio of Voxel changed from 40.76 % to 22.01 %, representing a -45.99% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Voxel since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Voxel with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Voxel

All Key Metrics — Voxel